Reinforcing 10+ years of clinical trial experience with a subcutaneous prophylaxis treatment, including the latest data in infants: Join the conversation with Dr. Mike Silvey (Sponsored by Genentech)

  Thursday, April 4, 2024           8:15 AM - 9:15 AM ET

Description

Please join us for an engaging program led by Dr. Mike Silvey as he shares his perspectives on managing patients with hemophilia A using a subcutaneous prophylactic treatment. The presentation will include the pivotal efficacy and safety data that is the foundation of the ongoing clinical trial program in patients with and without FVIII inhibitors, including an overview of real-world experience. He�ll also share updates from the latest trial in infants and previously untreated patients. The presentation will feature brain teasers, showcase social media that�s engaging the hemophilia community, and Mythbuster polls. Be sure to bring your questions to the Q&A following the program.